1de Bold A J. Bruneau B G, de Bold M L K. Mechanical and neuroendocrine regulation of the endocrine heart.Cardiovasc Res, 1996,31:7-18.
2Schirger J A, Grantthan J A, Kullo I J, et al. Vascular actions of brain natriuretic peptide:modulation by atherosclerosis and neutral endopeptidase inhibition. J Am Coll Cardiol, 2000, 35: 76 - 81.
3Flesicher D, Espiner E A, Yandle T G, et al. Rapid assay of plasma brain natriuretic peptide in the assessment of acute dyspnoea. N Z Med J,1997.10:71-74.
4Vogeser M, Jacob K. B-type natriuretic peptide-validation of an immediate response assay. Clin Lab, 2001,47:29-33.
5Cowie M R. Struthers A D M,Wood D A, et al. Value of natriuretic peptide in assessment of patients with possible new heart failure in primary care. Lancet, 1997,350: 1349- 1351.
6Dao Q. Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol,2001,37:379 -385.
7Davidson N C, Naos A A, Hanson J K, et al. Comparision of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction . Am J Cardiol,1996,77:828-831.
8Omland T, Aakvaag A, Bonarjee, W S,et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic dysfunction and long-term survival after acute myocardial infarction. Comparion with plasma atrial natriuretic peptide and N-terminal p
9Nagaya N, Goto Y, Nishikimi T M,et al. Sustained elevation of plasma levels of brain natriuretic peptide levels associated with progressive ventricular remodelling after acute myocardial infarction. Clin Sci, 1999,96:129-136.
10Task force for the diagnosis and treatment of chronic heart failure ESC. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J, 2001,22:1527-1560.
